Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NxStage Medical Inc (NASDAQ:NXTM)

16.56
Delayed Data
As of Sep 04
 +0.11 / +0.67%
Today’s Change
11.50
Today|||52-Week Range
19.63
-7.64%
Year-to-Date

Today’s Trading

Previous close16.45
Today’s open16.35
Day’s range16.28 - 16.70
Volume235,954
Average volume (3 months)592,991
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)+20.51%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.45%
P/E ratioNM
Price/Sales3.67
Price/Book5.45

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...+0.12+0.99%
EXELExelixis Inc+0.08+1.44%
AMRIAlbany Molecular Res...-0.01-0.05%
FGENFibroGen Inc+0.54+2.39%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$301.5M
Annual profit (last year)-$23.9M
Net profit margin-7.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Jeffrey H. Burbank
President
Joseph E. Turk
Corporate headquarters
Lawrence, Massachusetts

Forecasts

Partner Offers